123ArticleOnline Logo
Welcome to 123ArticleOnline.com!

ALL >> Business >> View Article

Harver Group Investing Heavily In Potential Cancer Cure

By Author: Harver Group
Total Articles: 26

Jul. 22, 2013 - CHUO-KU, Japan -- Harvard Bioscience Inc. (HBIO) has received little attention for their research from the medical establishment or from educational institutions. While posting consistent growth and a strong customer base, shareholders have not seen much profit to date due to operating losses from the company´s Regenerative Medical Device division also known as Harvard Apparatus Regenerative Technology.

“We believe that Harvard Bioscience Inc. is a solid investment now” said Peter Anderson Senior Vice President of Mergers and Acquisitions at Harver Group, “before Harvard Apparatus Regenerative Technology is given an initial public offering”.

Head of Investment Analysis, Mr. Nathan Marx said “Removing Harvard Apparatus from their balance sheets should lead to an increase in valuation of at least 50% in the short term and potentially 100% in the long term if shareholder friendly policies are enacted. We expect the IPO to happen within four months”.

Harvard Apparatus Regenerative Technology is pursing ground breaking research; they are preforming clinical trials of their cure for trachea cancer. The trials have produced very exciting results, with a high survival rate for a typically fatal form of cancer. They’ve created scaffolding, which in conjunction with cells from the patient construct a new trachea. This technology has further applications, for lung and heart, heart valve, liver, and kidney transplants as well as esophageal cancer.

Both the President and CFO of Harvard Bioscience Inc. will be leaving to run Harvard Apparatus Regenerative Technology. We believe that this indicates that a sale of Harvard Bioscience is in the works, due to the fact that the President and CFO along with other members of management own 14% of the company. Management will likely maximize value, and sell the company for at least $10 a share. We are recommending our clients to move on Harvard Bioscience Inc. as soon as possible and we will bring more news on Harvard Apparatus Research Technology IPO as we receive it.

Total Views: 68Word Count: 321See All articles From Author

Business Articles

1. Which Steps Are To Be Followed To Ensure Efficient Wastewater Recycling System
Author: Steve Cherng

2. Valhalla Mining Offers: What We Offer And Who We Are
Author: romyfernandis12

3. Should I Invest In Bitcoin In 2017? Here’s What You Need To Know
Author: romyfernandis12

4. Our Cryptocurrency Exchange And Bitcoin Mining Services Are The Best
Author: romyfernandis12

5. How Does Cryptocurrency Ming And Bitcoin Mining Work?
Author: romyfernandis12

6. Valhalla Mining - Service Overview, Technology, For Sellers, For Buyers The Benefits Of Cryptocurren
Author: romyfernandis12

7. Can You Make Profit With Bitcoin And Cryptocurrency Mining? Is Bitcoin Mining And Cryptocurrency Min
Author: romyfernandis12

8. A Beginners Guide To Cryptocurrency Mining: What Should You Know?
Author: romyfernandis12

9. Popular Established Sites That Appreciate Bitcoins And Cryptocurrency Mining.
Author: romyfernandis12

10. Disadvantages Of Cryptocurrency Mining
Author: romyfernandis12

11. 4 Reasons Why Merchandising Plays An Important Role In Retail Sales
Author: Lily Alvin

12. Have You Ever Read About Digital Currency Mining?
Author: romyfernandis12

13. Buying And Investing In Cryptocurrency
Author: romyfernandis12

14. Elucidation Of Bitcoin Cloud Mining
Author: romyfernandis12

15. Get Better Returns Than Stock Market And Real Estate Through Bitcoin Mining
Author: romyfernandis12

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: